Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women
Authors:
- Anita IversenAIAnita Iversen
- Hanne FrydenbergHFHanne Frydenberg
- Giske UrsinGUGiske Ursin
- Grazyna JasienskaGrazyna Jasienska
Open Access
- 1 January 2016
- journal article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 25 (1) , 9-18
Abstract
Estrogen and progesterone are key factors in the development of breast cancer, but it remains unclear whether these hormones are associated with mammographic density phenotypes in premenopausal women. We measured percent mammographic density, nondense area, and absolute mammographic density using computer-assisted breast density readings (Madena) from digitized mammograms taken on a scheduled day of the menstrual cycle (day 7-12) among 202 healthy, premenopausal women (Energy Balance and Breast cancer Aspects Study-I). Daily salivary concentrations of 17β-estradiol and progesterone throughout an entire menstrual cycle and fasting morning serum concentrations of hormones on 3 specific days of the menstrual cycle were assessed. Salivary and serum 17β-estradiol and progesterone were positively associated with percent mammographic density, we observed by 1 SD increase in overall salivary estradiol (β-value equal to 2.07, P=0.044), luteal salivary progesterone (β-value equal to 2.40, P=0.020). Women with above-median percent mammographic density had a 20% higher mean salivary 17β-estradiol level throughout the menstrual cycle. The odds ratio for having above-median percent mammographic density (>28.5%) per 1 SD increase in overall salivary 17β-estradiol was 1.66 (95% confidence interval 1.13-2.45). Women in the top tertile of the overall average daily 17β-estradiol concentrations had an odds ratio of 2.54 (confidence interval 1.05-6.16) of above-median percent mammographic density compared with women in the bottom tertile. Our finding of a relationship between estrogen, progesterone, and percent mammographic density and not with other mammographic density phenotypes in premenopausal women is biologically plausible, but needs to be replicated in larger studies.Keywords
This publication has 49 references indexed in Scilit:
- Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to the Time Since the MammogramCancer Epidemiology, Biomarkers & Prevention, 2013
- Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I studyHuman Reproduction, 2011
- Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Women's Health Initiative Randomized TrialJournal of Clinical Oncology, 2009
- 17- -Estradiol in relation to age at menarche and adult obesity in premenopausal womenHuman Reproduction, 2008
- Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal womenBreast Cancer Research and Treatment, 2007
- The association of mammographic density with ductal carcinoma in situof the breast: the Multiethnic CohortBreast Cancer Research, 2006
- Mammographic densities and circulating hormones: A cross-sectional study in premenopausal womenThe Breast, 2006
- Metabolic and Hormonal Profiles: HDL Cholesterol as a Plausible Biomarker of Breast Cancer Risk. The Norwegian EBBA StudyCancer Epidemiology, Biomarkers & Prevention, 2005
- The association of breast mitogens with mammographic densitiesBritish Journal of Cancer, 2002
- Epidemiology of Endocrine-Related Risk Factors for Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2002